How would you rate your Medical Device company’s ability to assess the financial impact of product changes?
In a recent survey conducted by analyst firm Axendia, a group of medical device manufacturers was asked about the characteristics of their change management processes and systems.
Surprisingly, most companies are not able to clearly quantify the financial impact of potential product changes. Only 2% of the companies said their ability to estimate the costs of product changes was excellent. 10% assessed their ability as poor, with the majority of companies rating their ability as average.
This content is sponsored by:
